Cheaper AI models are changing how businesses manage AI costs in 2026 as token bills rise and South African firms watch ...

Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, today announced a strategic collaboration agreement with Takeda to use its proprietary end-to-end platform, Pharma.AI, ...

For most of the industrial era, work meant output. You were valued for what you produced, how fast you produced it and how ...

With the explosive growth of generative artificial intelligence (Generative AI) technology, AI has evolved from simple ...

Across industries, artificial intelligence is entering a more disciplined phase. While the early cycle rewarded novelty, the ...

In the AI era, your greatest competitive advantage isn't your product. It's the community you build around it.

Colleges need to invest in creating welcoming, AI-free learning spaces.

Insilico Medicine ("Insilico" HKEX:3696), a leader in clinical-stage generative AI for drug discovery, today announced a strategic collaboration agreement with Takeda to use its proprietary end-to-end ...

In a high-stakes corporate investigation, regulatory response, or litigation event, where is the critical "smoking gun" evidence hiding today?

The old playbook of buying high-volume, low-cost backlinks is officially obsolete. In 2026, links are no longer just v ...

Contrary to perceptions of India lacking its own AI giants, global companies are actively developing cutting-edge AI products within the country. Indian engineers are instrumental in creating ...